NCT05855707View on ClinicalTrials.gov

Wharton Jelly Mesenchymal Stromal Cells as GVHD Prophylaxis

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

September 30, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions

Allogeneic DiseaseGVHD,AcuteGraft Failure

Interventions

BIOLOGICAL

WJ-MSC infusion

cellular therapy

All Listed Sponsors

collaborator

Saint-Louis Hospital, Paris, France

OTHER

lead

Central Hospital, Nancy, France

OTHER